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Adipogenesis is regulated by a complex cascade of transcriptional factors, but little is known about the
early events that regulate the adipogenic program. Here, we report the role of the srebf1a gene in the
differentiation of fibroblastic 3T3-F442A cells. We found that expression of srebf1a depended on GSK3b
activity and that GSK3b activity was necessary for C/EBPb phosphorylation at Thr188. Knockdown of
srebf1a inhibited the adipogenic program because it blocked the expression of genes encoding PPARc2,
C/EBPa, SREBP1c and even FABP4, demonstrating that SREBP1a activation is upstream of these three
essential adipogenic transcription factors. Kinetic analysis during differentiation illustrated that the order
of expression of adipogenic genes was the following: cebpb, srebf1a, pparg2, cebpa, srebp1c and fabp4. Our
data suggest that srebf1a acts as an essential link between the GSK3b-C/EBPb signaling axis and the
beginning of the adipogenic transcriptional cascade.
W
hite adipose tissue plays an important role in energy storage and organismal homeostasis through
secretion of molecules with endocrine activities. The study of adipose differentiation has been highly
facilitated by cell culture models, such as the fibroblastic 3T3-L1 and the 3T3-F442A cell lines. Both
sister cell lines undergo adipose differentiation following stimulation with adipogenic serum proteins or growth
hormones
1–4.3T3-F442Acellshavetheabilitytodifferentiateintofatpadsinvivo,suggestingthattheyrespondto
physiological signals in the body
5, whereas 3T3-L1 cells do not
6. 3T3-F442A cells can also differentiate into an
osteoblast phenotype
7, demonstrating the plasticity of this cell line. Thus, the 3T3-F442A cell line is suitable for
the study of adipose differentiation, adipogenesis-regulating molecules and the expression of very early genes
involved in this pathway.
Adipogenesis has previously been studied in culture conditions using highly adipogenic serum that is supple-
mented without or with molecules such as methyl isobutyl xanthine (MIX) and dexamethasone (Dex) that
enhance adipose conversion
8. However, none of these molecules have been shown to induce commitment in
the absence of adipogenic serum. The use of small molecules to assist in adipocyte 3T3-F442A cells conversion
providestheopportunitytostudysomeofthemechanismsinvolvedintheearlystagesofdifferentiation.Suchan
approach also facilitates the examination of signaling and transcriptional cascades involved in adipogenesis and
discriminates between other stimulated pathways that could be unnecessarily and simultaneously activated by
serum or growth hormones.
Recently, we demonstrated the ability of staurosporine (St) to induce adipose differentiation in the absence of
adipogenic proteins
9 and the ability of dexamethasone (Dex) to enhance differentiation of 3T3-F442A cells
induced with St
10. This model offers the following two advantages: 1) St/Dex can promote a maximum differ-
entiation in 4 h without adipogenic serum (incubation with the serum alone requires approximately 48 h for the
cells to reach the same level of adipogenesis
9); and 2) St induces two well-defined stages for differentiation before
clonal expansion that then permit the identification and analysis of early gene regulation. The first stage consists
of 4 h of induction, where St induces progenitor cells to differentiate, and the second stage consists of a sub-
sequent44 hofstabilization,wheredifferentiationcontinuesintheabsenceoftheinducerbutcanstillbereversed
byanti-adipogenicsubstances orcytokines
9.Itisimportanttonote,thatthismodelof3T3-F442Acells,allowsan
earlyresponsetoadipogenesis,sinceonly4 hoursoftreatmentwithStissufficienttotriggertheadiposeprogram,
whereas adipogenic serum and MIX/Dex require, at least, 48 hours for induction in 3T3-L1 cells
8. All the studies
published with the 3T3-L1 cells are carried out in medium supplemented with adipogenic serum during growth
phaseoftheculture,andMIX/Dexareaddedlateratconfluencytoenhanceadiposeconversion.The3T3-L1cells
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of MIX/Dex, which later were found to enhance, but not initiate
adipose conversion
2,8. These data, shows that the 3T3-F442A model
we are using, is suitable to carry out kinetic analysis of gene expres-
sion, mainly during the early stages of induction.
Studies using cell lines have shown that a complex cascade of
transcription factors is engaged in the generation of fat cells
11. The
peroxisome proliferator activated receptor gamma (PPARc, pparg),
particularly isoform 2, and CCAAT enhancer binding protein alpha
(C/EBPa, cebpa) are considered the orchestrators of adipogenesis,
and their expression patterns determine adipose differentiation
12–14.
Also,ithasbeensuggestedthatin3T3-L1cells,expressionofPPARc
to promote adipogenesis depends on glucocorticoids, cAMP and
serum mitogens via C/EBPb
11.
The principal transcription factor involved in the early steps of
adipogenesis is C/EBPb (gene: cebpb). Its expression precedes the
expression of pparg2 and cebpa by approximately 30 h
15, raising the
question of whether other genes that are expressed such a long time
after cebpb expression can regulate the expression of pparg2 and
cebpa.
The Sterol Responsive Element Binding Proteins (SREBPs) are
transcription factors encoded by the srebf1 and srebf2 genes.
Recently, the importance of the SREBPs has been highlighted; these
proteins function as the central hubs in lipid metabolism
16. Using
genome-wide expression analysis, we identified srebf1 as an early
gene induced during adipogenesis of 3T3-F442A cells. The srebf1
gene encodes two proteins, SREBP1a and SREBP1c, with isoform
-1c being the predominant isoform in most tissues analyzed
17.
However, the roles of SREBP1a and -1c during the early events of
adipogenesis remain unknown. In this study, we found that srebf1a
wasexpressedveryearlyininductionandprecededtheexpressionof
all other adipogenic genes, including pparg2, cebpa, srebf1c and
fabp4. Loss-of-function experiments revealed that expression of
srebf1awasnecessaryforadipogenesis.Wealsoshowedthatexpress-
ion of srebf1a depended on the activity of GSK3b probably via the
phosphorylation of C/EBPb and that GSK3b activity played an
essential regulatory role in the very early stages of induction of adi-
pogenesis and maintenance of the adipose cell phenotype. Our
results indicate the importance of the srebf1a gene during early adi-
pogenesis and demonstrate that srebf1a acts as a link between the
GSK3b-dependent signaling pathway and the beginning of the tran-
scriptional cascade that results in the expression of pparg2.
Results
Adipogenesis involves lineage commitment, clonal amplification of
committed cells, and expression of the adipose cell phenotype. In
3T3-F442A cells, replication of DNA and clonal amplification pre-
cede the expression of the adipose phenotype when cells are induced
to differentiate upon treatment with adipogenic serum
18. Clonal
amplification, which marks the beginning of adipose phenotype
expression, has been shown to occur approximately 68 h after adi-
pogenic serum supplementation in non-differentiating resting cul-
tures, and DNA synthesis takes place about 12 h earlier
18. Because
adipogenesis of 3T3-F442A cells has been shown to occur more
rapidly following induction with St/Dex compared to adipogenic
serum
9, we attempted to identify the time course of clonal amplifica-
tion under these conditions. Two-day post-confluent cultures of
3T3-F442A cells were incubated in DMEM (Dulbecco’s Modified
Eagle Medium) containing non-adipogenic serum with St/Dex for
4 h to induce cells to differentiate. At various time points, cell num-
bers were assessed in each culture. We found that the total cell
number increased approximately 56 h following treatment, which
corresponded to clonal amplification (Figure 1A). Based on our
previous data, these results suggested that DNA synthesis likely
occurred about 44 h into induction. In combination with previously
described studies
9, our data demonstrate the following two early
stages for for differentiation: a 4-hour induction stage initiated by
St/Dex,followedbyastabilizationstagethatlastsupto44 h,whichis
followed by DNA synthesis and clonal amplification at 56 h post-
treatment with St/Dex (Figure 1B). Diaz-Velasquez et al. (2008)
found that at about 14 h after clonal amplification, the activity of
the lipogenic enzyme, glycerol phosphate dehydrogenase, an early
marker of phenotypic expression, began to increase in a time-
dependent manner. These results are essential to more precisely
identify the molecular events that regulate each adipogenesis stage.
To quantify differentiation into adipocytes, we counted the num-
ber of adipocyte clusters in cultures at the conclusion of the experi-
ment. Cells induced to differentiate into adipocytes form adipose
clusters
9, and as each cluster arises from the selective multiplication
of one parental cell
19, the number of adipose clusters corresponds to
the number of induced cells. When we cultured 3T3-F442A cells in
non-adipogenic conditions and then induced them with St/Dex for
4 h, differentiation to adipocytes was 10-fold higher compared to
non-induced cultures, and the number of adipocyte clusters was in
agreement with the number of adipose clusters observed in cultures
incubated with fetal bovine serum, which is highly adipogenic
(Figure 1C).
The genes coding for the SREBPs are early and highly expressed
during differentiation of 3T3-F442A cells. We performed a global
screening using genome-wide expression microarrays to identify
genes that may be involved in the various stages of adipogenesis.
We compared 3T3-F442A cells under three distinct culture
conditions: 1) cells in the induction stage with St/Dex (4 h); 2)
cells in the stabilization stage (30 h from induction, prior to clonal
amplification); and 3) cells in the phenotype expression stage
(144 h), which consisted primarily of terminally differentiated
mature adipocytes. We observed an early increase in the expres-
sion of the srebf1 gene. This gene differentially expresses two
isoforms, -1a and -1c; however, microarray analyses did not reveal
isoform-specific expression changes (data not shown).
Although the participation of the srebf1 gene in lipid metabolism
has been described, the roles of the -1a and -1c isoforms have not
been documented. Our results demonstrated that compared to non-
induced cells, expression levels of both isoforms of the srebf1 gene
wereincreased several foldduring induction andstabilization stages,
and these levels continued to increase (Figure 1D). The Srebf1a iso-
form showed a rapid and sharp increase in expression after 4 h of
induction, and by the stabilization stage (8 h), the expression of
srebf1a reached a maximum level at about 15-fold, which was
maintained thereafter. During the first 3 h of the induction stage,
srebf1a expression remained at levels similar to non-induced cells
(Figure 1E). Srebf1c expression increased significantly at the end of
the stabilization stage (48 h), reaching a maximum of 350-fold well
into the phenotypic expression stage (72 h), and remained at those
levels during terminal differentiation, forming mature adipocytes
(Figure 1D). It is remarkable that during commitment, expression
of srebf1a was higher than srebf1c and it took about 60 h longer
for srebf1c to reach its maximum level of expression compared with
srebf1a (Figure 1D). Srebf2, the third isoform in this family,
which regulates cholesterol metabolism, did not undergo any signi-
ficant change in expression in either of the culture conditions
(Figure 1D), suggesting that cholesterol metabolism was not signifi-
cantlystimulatedduringadiposeconversion.Inagreementwiththis,
other studies have shown that total cholesterol synthesis is not
altered during 3T3-L1 fat cell differentiation
1.
The increase in srebf1a expression preceded the changes in the
expression of other genes that have been described as characteristic
regulators of 3T3 cell adipogenesis. We found that expression of
pparg2, the regarded master regulator of adipogenesis
14, did not
change during induction but began to increase after 8 h and was
50-fold higher by the end of stabilization (48 h); at the phenotypic
www.nature.com/scientificreports
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140-fold higher (Figure 1D, E). The cebpa gene did not show any
change in expression during induction, but its expression was
increased (12-fold) at the end of the stabilization stage, reaching its
maximum (160-fold) after clonal expansion and at the beginning of
phenotype expression (72 h) (Figure 1D).
The fabp4 gene, which encodes aP2, a lipidcarrier expressed during
adipose differentiation
20, had similar expression kinetics as cebpa;
fabp4 reached its maximum level of expression of 108-fold in termin-
ally differentiated adipocytes (Figure 1D). The expression of cebpb
transiently increased (6-fold) during the 4 h induction stage but
returned quickly to the basal levels found in non-induced cells by
8 h (Figure 1D, E). The early and transient increase in expression
was accompanied by changes in the phosphorylation state of the C/
EBPb protein.
The expression kinetics for each gene was different. To more pre-
cisely identify the time at which expression of each gene began to
increase, we determined the mathematical equation for each kinetic
plot. We used the second derivative of each function and calculated
the inflection point of the derivative that corresponded to the time
point at which expression of each gene began to increase. We
observed the following time course of gene expression (Figure 1F):
srebf1a was the first expressed gene, with expression beginning
at less than 1 h of the induction stage. The other genes began to be
expressedwellintothestabilizationstageofcommitment.Increasing
expression levels of pparg2 followed the expression of srebf1a, and
then cebpa, srebf1c and fabp4 expression followed. This analysis
demonstrated that these genes began to be expressed during induc-
tion and stabilization and likely before clonal expansion. It also sug-
gests that SREBP1a may be the transcription factor that orchestrates
Figure 1 | Expression of srebf1a and adipogenic genes during adipose differentiation of 3T3-F442A cells. (A) Clonal expansion of 3T3-F442A cells induced
to differentiate with staurosporine and dexamethasone (St/Dex). Post-confluent 3T3-F442A cells were induced to differentiate into adipose cells with St/Dex
for 4 hfollowedby incubation in non-adipogenicconditions (N-Ad). Cells were harvested andcounted at the indicated times. (B) Schematic representationof
the time course of the adipogenic program induced by St/Dex. The main stages are shown at the indicated time frames. (C) Adipose conversion in post-
confluent cultures induced with fetal bovine serum (FBS) for 48 h or St/Dex for 4 h in non-adipogenic medium. After induction, cultures were switched to
non-adipogenic medium and grown for 144 h. Adipose clusters were assessed by staining with Oil Red O. (D) and (E) Expression of srebf1a and other
adipogenic genes. Post-confluent cultures under non-adipogenic conditions (N-Ad) or induced with St/Dex were harvested at different time points, and gene
expression was evaluated by qRT-PCR. (F) The calculated time for the increase in the expression of adipogenic genes based on the gene expression kinetics.
Briefly, we calculated the fit curve at a maximal R
2 and determined the inflection points from the second derivative. Data are presented as the mean 6 s.d.
www.nature.com/scientificreports
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adipogenic master regulator.
Withtheavailabledataoncebpbexpression,wecouldnotcalculate
the second derivative, but there was a significant increase in cebpb
expression that clearly occurred in the first hour of induction
(Figure1E).Thus,cebpbandsrebf1awerethetwogenesthatchanged
their expression in the very early stage of induction.
Lossoffunctionofsrebf1ainhibitsadiposedifferentiationof3T3-
F442A cells. To study the necessity of the expression of the srebf1a
gene, we knocked down its expression by shRNA targeting. 3T3-
F442A cells were transfected with the pSingle-shSRE1a vector,
which expresses an shRNA targeting srebf1a upon treatment with
doxycycline. After transfection, cells were seeded and induced to
differentiate with St/Dex. Silencing of the srebf1a gene by pSingle-
shSRE1a led to about a 70% inhibition in srebf1a mRNA expres-
sion compared to control cultures not treated with doxycycline
(Figure 2A). As expected, parallel cultures transfected with a vector
containinganon-relatedsequencedidnotshowsilencingofthegene
(results not shown). The expression of the adipogenic genes that are
characteristic of adipose differentiation, including pparg2, cebpa and
srebf1c, also decreased by an amount similar to srebf1a (Figure 2A).
These results demonstrate that SREBP1a activity is upstream of
pparg2, cebpa and srebf1c and that SREBP1a is required for the
regulation of these adipogenic genes.
GSK3b regulates the expression of srebf1a through C/EBPb
phosphorylation. The C/EBPb protein is a transcription factor
that targets distinct genes in several tissues. Phosphorylation of C/
EBPb is required for DNA binding and determines the specificity of
target genes transactivated by C/EBPb. For the adipogenic program,
phosphorylation of C/EBPb at Thr188 is required. Phosphorylation
of Thr188 could be mediated by ERK or GSK3b, as Thr188 is part
of the ERK/GSK3 phosphorylation consensus site
21. An antibody
against phospho-C/EBPb Thr188 showed that phosphorylation of
the protein began to increase within 0.5 h of the induction stage,
reaching a maximum at 2 h, and then it began to decrease to basal
levels after 4 h, corresponding with the end of the induction stage
(Figure 2B). Our results also showed that this phosphorylation event
preceded the expression of various adipogenic genes, including
srebf1a, the earliest expressed gene in the adipogenic pathway
(compare Figure 2B with Figure 1D and E). We have previously
demonstrated that GSK3b activity is essential for the induction of
the adipogenic program
9. The activity of GSK3b is regulated by
Figure 2 | Srebf1a is necessary for adipogenesis of 3T3-F442A cells. (A) Knockdown of srebf1a expression by specific shRNA blocks the adipogenic
program.3T3-F442AcellsweretransfectedwithpSingle-shSRE1acontainingaspecific shRNAagainstsrebf1a.Transfectedcellsweretheninducedtothe
adipogenic program with St/Dex for 4 h. Expression of shRNA was induced by doxycycline (Dox), and gene expression was evaluated by qRT-PCR
at 48 h after induction. (B) St/Dex induced early phosphorylation of C/EBPb at Thr188 during adipocyte differentiation. Cultures of 3T3-F442A cells
were induced with St/Dex, and total protein was extracted and immunoblotted at the indicated times. (C) St/Dex induction stimulates GSK3b
phosphorylation atTyr216.Protein extractsfrom3T3-F442Acells attimezero(T0)innon-adipogenicconditions at4 h(N-Ad)orinduced withSt/Dex
for4 hwereimmunoblottedwithspecificantibodies.(D)InhibitionofGSK3bactivityinhibitsphosphorylationofC/EBPbatThr188.Cellswereinduced
with St/Dex for 4 h, and cultures were then switched to fresh medium supplemented with 50 mM SB415286 (SB), a specific inhibitor of GSK3b activity,
for 20 h. Protein extracts were obtained at time zero (T0) or in the presence (SB) or absence (St/Dex) of the inhibitor and analyzed by immunoblotting.
(E)GSK3bactivityisnecessaryfortheexpressionoftheadipogenicgenesandsubsequentadipocytedifferentiation.CellsweretreatedasinD.Culturesin
thepresence(SB)orabsence(St/Dex)ofSB415286werefollowedfor144 htoevaluateadiposeconversion.Geneexpressionwasevaluatedattheindicated
times by qRT-PCR. Data are presented as the mean 6 s.d.
www.nature.com/scientificreports
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Tyr216 activates the kinase, but phosphorylation at Ser9 inactivates
the kinase even in the presence of Tyr216 phosphorylation
22. In cul-
tures induced with St/Dex, we found that GSK3b phosphorylated at
Tyr216wasthemorepredominantformthanGSK3bphosphorylated
at Ser9 (Figure 2C). By densitometric analysis of the immunoblots,
GSK3b-Tyr216 was approximately 80% more abundant than the
inactive form of GSK3b,G S K 3 b-Ser9 (Figure 2C). We also inhi-
bited the activity of GSK3b using its selective inhibitor, SB415286.
Phosphorylation of C/EBPb at Thr188 was completely abolished in
cultures treated with SB415286 (Figure 2D). These results strongly
suggest that the activity of GSK3b regulates the phosphorylation of
C/EBPb.
The GSK3b inhibitor, SB415286, also blocked the expression of
the adipogenic genes tested and thus prevented adipose differenti-
ation (Figure 2E). We next analyzed the promoter sequence of the
srebf1 gene. Murine srebf1 has two separate promoters that give rise
to isoforms -1a and -1c; these forms mutually exclude each other
17.
Sequence analysis of the srebf1a promoter using the TFSearch algo-
rithm
23revealedtheexistenceofatleast5putativebindingsitesforC/
EBPb between positions 21075 to 23527. Additionally, there was a
consensus site for C/EBP at position 2841. These results show that
GSK3b is involved in regulating phosphorylation and activation of
C/EBPband thatthis transcription factoris required totransactivate
srebf1a expression, leading to the early steps of adipogenesis.
PPARc does not transactivate srebf1a expression. We showed that
srebf1a is one of the earliest genes expressed during the adipogenic
program,evenpriortopparg2expression(Figure1D,E).Srebf1cand
srebf1ashareahighlevelofsequencehomologyanddifferinthefirst
exon; here, SREBP1a is 24 amino acid residues longer. Sequence
analysis of the srebf1c promoter revealed a putative binding site for
PPARc that was about 26900 bp from the transcription start site.
Similar analyses of the srebf1a promoter did not reveal any
recognition site for PPARc. To date, there has been no ex-
perimental evidence that PPARc transactivates the expression of
srebf1a or -1c. Nevertheless, due to the high homology between
srebf1a and -1c and the putative binding site for PPARc in the
srebf1c promoter, it is conceivable that basal levels of PPARc in
pre-adipocytes could be sufficient to transactivate, either directly
or indirectly, the expression of srebf1a or -1c.
To exert its transcriptional activity, PPARc requires an endogen-
ouslipidligand
14,butrosiglitazone(Ros),asyntheticligand,canalso
activate the transcriptional function of PPARc
24. Therefore, we
attempted to identify by functional experiments with Ros whether
srebf1a or -1c expression relied on PPARc transcriptional activity.
Early treatment with Ros during induction should activate the basal
levels of PPARc and thus transactivate PPARc target genes. This
process would be evident by an early shift in the expression curve
of those genes. We induced post-confluent cultures of 3T3-F442A
cellswithSt/DexandthenaddedRostotheculturesduringinduction
(0–4 h). Cultures were maintained for up to 144 h to assess adipose
conversion. Gene expression was evaluated by qRT-PCR at various
time points.
Rosacceleratedtheexpressionofpparg2,cebpa,srebf1c,andfabp4,
suggestingthatRosactivationofbasalPPARcleadstoincreasedself-
activation and the transactivation of cebpa, srebf1c, and fabp4. More
importantly, srebf1a expression did not increase upon addition of
Ros(Figure3A),demonstratingthattheexpressionofthisgeneisnot
undertheregulationofPPARcorothertranscriptionfactorsthatare
responsive to this drug.
In parallel cultures, we determined the number of adipose clusters
at the end of the experiment. We found that the number of adipose
clusters was similar in all culture conditions either with or without
Ros (Figure 3B). This indicated that the accelerated gene expres-
sion did not increase induction into differentiation of the adipose
precursors in the cultures. However, the cluster size was larger in the
cellstreatedwithRos(Figure3C),suggestingthattheearlyactivation
of the genes might lead to higher adipose conversion through larger
adipose clusters and/or higher lipid accumulation.
Discussion
Adipose differentiation of 3T3 cells is regulated by networks of tran-
scriptional factors
11. Cebpb is one of the earliest transcription factors
expressed during adipose differentiation, and it precedes pparg2 and
cebpa expression by 30 h
15. Recently, SREBPs have been regarded as
important central hubs in lipid metabolism
16.
The ratio of the SREBP1c protein to the -1a protein varies widely
in different tissues. The -1c isoform is more abundant in adipose
tissue and liver than the -1a isoform
17, although -1a shows higher
transcriptional activity
25. Deletion of srebf1a is lethal to the embryo,
suggesting an unknown important role of the protein during embry-
onic development
26. Overexpression of srebf1a in transgenic mice
produced adipocyte hypertrophy and fatty liver
27. These and other
data suggest that isoforms -1a and -1c may be controlled indepen-
dently, and the two may respond differentially to organ-specific and
metabolic factors
17. Despite the key function of these transcription
factors in lipid homeostasis, a role for SREBP1a in adipose differ-
entiation has not been reported.
Tostudytheadipogenesisprogram,wetookadvantageofthetwo-
stagemodelin3T3-F442Acells,whichincludesaninductionstageof
4 h followed by stabilization for 44 h, a time in which the adipogenic
inducer is no longer required
9. We also used St as a specific small
molecule to induce differentiation without any adipogenic proteins
9,
circumventing the ERK/MAPK signaling pathway that is activated
by serum adipogenic proteins or growth hormone to promote adi-
pogenesis
28.IthasbeendescribedthatStdirectlyactivatesGSK3b
29,a
molecular switch in the Wnt pathway. Here, we report that GSK3b
induces C/EBPb phosphorylation at Thr188, which then promotes
the expression of the srebf1a transcription factor. These events pre-
cedetheexpressionofpparg2andcebpa,andregulatetheearlystages
of adipogenesis. As deletion of srebf1a leads to embryonic lethality
30,
expression studies of this gene in 3T3-F442A cells offer a suitable
experimental model to elucidate the role of this transcription factor
during adipogenesis. The early expression of srebf1a and the loss-of-
function experiments showed that the expression of srebf1a was
essential for adipogenesis through regulation of pparg2, cebpa and
srebf1c. Srebf1a expression increased at least 10-fold in the 4 h of the
induction stage and increased prior to augmentation of pparg2
expression, which occurred after the induction stage. After the indu-
cer (St/Dex) was removed, cells were at the stage of stabilization well
after srebf1a mRNA had reached its maximum level. Therefore, the
well-known, adipogenic transcriptional cascade involving PPARc is
activated after the cells have begun to express srebf1a and no longer
require an inducing agent.
ADD1/SREBP1
31, which was later identified to be the -1c isoform,
does not bind to the pparg2 promoter
32, but it can activate PPARc
through the production of a fatty acid derivative, which acts as an
endogenous ligand
33. Analysis of the pparg2 sequence with the
TFSearch algorithm did not reveal any recognition site in its pro-
moter region for binding of SREBP1a or -1c. However, the same
analysis of the srebf1c promoter revealed a recognition site for
PPARc.Incombinationwithpreviouswork,ourdatademonstrating
the up-regulation of srebf1c after pparg2 and the accelerated expres-
sion of srebf1c in the presence of Ros (an exogenous ligand for
PPARc activation) support the idea that PPARc may directly regu-
late srebf1c expression. Additionally, in the phenotype expression
stage, a mutual regulation of PPARc and SREBP1c may take place
to regulate adipogenesis and lipid metabolism through a feedback
loop, where PPARc transactivates srebf1c expression, and SREBP1c
produces an internal ligand to activate PPARc (Figure 3D). Due to
the lack of a recognition site for SREBP1a in the pparg2 promoter
www.nature.com/scientificreports
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produce an intermediary that transactivates pparg2 and upregulates
its expression, warranting further investigation into a possible path-
way of pparg2 regulation by SREBP1a (Figure 3D).
SREBP1aappearstobethestrongestactivatorofSterolResponsive
Element (SRE), SRE-like and E-box sequences
25. Previous work has
shown that SREBP1a and -2, but not -1c, transactivate SRE binding
sitesfoundincholesterogenicgenes
25.SREBP1aand-1ctransactivate
targets with E-box sequences in their promoters to activate the lipo-
genic pathway
25. Interestingly, SREBP1c has an SRE binding site in
its promoter
34, suggesting that SREBP1a could transactivate it.
Analysis of the promoter sequence of srebf1a did not show any
SRE or E-box binding sites. Srebf1a appears to have a constitutively
low expression pattern in liver, but its overexpression in transgenic
mice leads to liver steatosis
35, which is consistent with a report indi-
cating that the activation of the lipogenic program could also occur
through SREBP1a
25. Based on our data, we propose that an SRE
binding site in srebf1c could be occupied by SREBP1a to trigger
srebf1c expression, which then contributes to the activation of the
lipogenic program. It is conceivable that SREBP1a activates expres-
sion of srebf1c, and because it is required for expression of pparg2
either directly or indirectly, it would contribute to a feedback loop
among these three factors and trigger the rest of the transcriptional
adipogeniccascade(Figure3D).ThefeedbackloopsbetweenPPARc
and CEBPa
36 and between SREBP1a, SREBP1c and PPARc des-
cribed here raise the possibility that they not only regulate induction
to adipogenesis but also have a regulatory function in lipid metabol-
ism, as their genes remain highly expressed in mature adipocytes.
One of the early steps for adipose conversion is the inhibition of
the Wnt pathway
37. The Wnt pathway maintains pre-adipocytes in
an undifferentiated state
37, and direct activation of GSK3b inhibits
intracellular Wnt signaling
38. Staurosporine activates GSK3b by
maintaining its Tyr216 phosphorylation, which is the active state
oftheenzyme
29.Ourresultsshowthatstaurosporineinducesadipose
conversion by preserving GSK3b phosphorylation at Tyr216, which
is subsequently required to induce C/EBPb phosphorylation. This is
followed by the expression of srebf1a during the first 4 h of induc-
tion. After this point, the cells enter an intrinsic and autonomous
pathway of commitment without the involvement of St or other
adipogenic factors. The persistent GSK3b activity has been found
to be required not only for induction but also for its subsequent
stabilization and clonal amplification of adipogenic cells
9. Some of
Figure 3 | Srebf1a expression does not depend on PPARc transcriptional activity. (A) Rosiglitazone (Ros), a potent PPARc activator, accelerates the
expression of adipogenic genes, but not of srebf1a. Post-confluent cultures were induced with St/Dex supplemented with 1 mM Ros during induction.
GeneexpressionwasdeterminedbyqRT-PCR.(B)Adiposedifferentiation inducedwithSt/DexwithandwithoutRos.Dataarepresentedasthemean6
s.d.(C)RepresentativeculturesdifferentiatedinthepresenceorabsenceofRos;notethattheadiposeclusterstreatedwithRosarelargerinsizeandmore
intenselystainedwithOilRedO.N-Ad, non-adipogenic condition.(D) Schematicrepresentation ofthe proposedsignaling pathwayandtranscriptional
cascade during adipogenesis. The data show that the early expression of srebf1a depends on GSK3b activity, and the expression of srebf1a is necessary for
the expression of the adipogenic genes, pparg, cebpa and srebf1c.
www.nature.com/scientificreports
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ing differentiation include persistent protein kinase activation, tran-
scriptionalautoactivation, andlatestabilization ofgeneexpression
39.
Because GSK3b remains active for progression into intrinsic signal-
ingduringcommitment,terminaldifferentiationofadiposecellsand
lipid metabolism, this kinase should have a crucial role during adi-
pogenesis. The persistent activation of GSK3b is due to its autopho-
sphorylation on Tyr216 that is initially mediated by chaperone
proteins, but after maturation of the kinase, the chaperone proteins
are no longer required
40.
Morerecently,ithasbeenshownthattwoadditionaltranscription
factor genes, klf4 and klf5, are expressed early during 3T3-L1 cell
adipogenesis. KLF4 binds to the cebpb promoter
41. Klf5 expression is
induced by C/EBPb and C/EBPd, and it has been suggested that
KLF5 directly affects the expression of pparg2 and cebpa, probably
by forming an enhanceosome with C/EBPb/d on the pparg2 pro-
moter
42. Despite the possible differences between the principal adi-
pogenesismodels,the3T3-L1and3T3-F442Acells,itisclearthatthe
expression of klf4, klf5 and srebf1a occurs very early. Based on data
from this and other studies, we propose that induction of adipocyte
commitment involves the following (see Figure 3D): 1) inhibition of
the Wnt pathway through GSK3b activation; 2) KLF4 binding to the
cebpb promoter, activation of CEBPb through induction of phos-
phorylationbyGSK3b,andexpressionofsrebf1aviaphosphorylated
CEBPb; and 3) following activation of cebpb by KLF4, one pathway
could involve klf5 and another srebf1a, with both pathways conver-
ging on the expression of pparg2. It is equally likely that the express-
ion of srebf1a and klf5 are coordinated and not independently
regulated. This could be explored by determining the expression of
klf5 in cells in which srebf1a is knocked down. Finally, after the
expression of klf4, klf5 and srebf1a during the early stage of adipo-
genesis and without the requirement of the inducer, cells continue
through the stabilization stage with the expression of pparg2, cebpa
and srebf1c. The progression into these stages during points to a
regulatorytranscriptionalcascadeforadipogenesisthatismorecom-
plexthanpreviouslythought.Thenecessityofsrebf1aexpressionand
thepresenceoffeedbackloopsbetweenSREPB1a/1candPPARcand
between CEBPa and PPARc (Figure 3D) suggest the existence of
finelytunedregulatorypathwaysinvolvingtheSREBP1transcription
factors in adipose biology. These possible alternate pathways for
adipogenesis warrants further study into these new lines of invest-
igation. Several crucial points of adipogenesis regulation emerge
from our data and offer new insights on obesity and its related
pathologies. Our studies point to the activity of GSK3b and
SREBP1a/1c as new control points for adipogenesis and, thus, new
targets for therapeutic intervention in obesity and diabetes. It is
important to note from our studies and others that adipogenesis
induction or stimulation by various substances (St/Dex, adipogenic
proteins, growth hormones or MIX/Dex) all require GSK3b activa-
tion. Therefore, this kinase appears to have a crucial function as
the molecular switch to initiate a differentiation program. Our
data clearly demonstrate the requirement for persistent activation
of GSK3b during all stages of adipose differentiation and phenotype
expression and its close relationship with SREBP1a, indicating
the importance of these molecules as regulatory factors for lipid
homeostasis.
Methods
Materials. Eagle’s medium modified by Dulbecco and Vo ¨gt (DMEM) and TRIzolH
solution were purchased from Invitrogen-Life Technologies (Carlsbad, CA). Adult
bovineserum wasfromM.A.Bioproducts(Walkersville,MD).Weobtainedadultcat
serum by bleeding domestic adult cats in accordance with the NIH guidelines for the
welfareofresearchanimals.EpidermalgrowthfactorwasfromIMCERABioproducts
Inc. (Terre Haute, IN). Insulin, d-biotin, human transferrin, triiodothyronine,
staurosporine, dexamethasone, b-mercaptoethanol, Oil Red O, dimethyl sulfoxide,
3-[(3-Chloro-4-hydroxyphenyl)amino]-4-(2-nitrophenyl)-1H-pyrrol-2,5-dione
(SB415286), and rosiglitazone were all from Sigma-Aldrich Corp. (Saint Louis, MO).
All other reagents were of analytical grade.
Cell culture and induction of adipose differentiation. The 3T3-F442A cells were
seeded in culture dishes at 1.25310
3 cell/cm
2 in non-adipogenic growing medium
consisting of DMEM supplemented with 4% adult cat serum, 5 mg/ml insulin and
1 mM d-biotin
3,10. For experiments, one- to two-day post-confluent cultures were
grown in non-adipogenic medium containing DMEM supplemented with 2% adult
cat serum, 0.2% adult bovine serum, 5 mg/ml insulin, 5 mg/ml transferrin, 1 mMd -
biotin,2 nMtriiodothyronine, 40 mMb-mercaptoethanoland 0.01 ng/mlepidermal
growth factor
4. Adipogenesis was induced in post-confluent cultures with
staurosporine (St) and dexamethasone (Dex) for 4 h in the non-adipogenic medium
as previously described
9,10. Cultures were incubated for up to 144 h, and adipose
conversion was evaluated by counting adipose clusters stained with Oil Red O
43.A l l
cultures were incubated at 37uC in a 10% CO2 atmosphere.
Short hairpin RNA cloning and cell transfection. A short hairpin RNA (shRNA;
Supplementary Table S1) against srebf1a mRNA was cloned into the pSingle-tTS-
shRNA plasmid (Clontech Laboratories; Mountain View, CA) at the XhoI and
HindIII cloning sites. The resulting construct was termed pSingle-shSRE1a.
Expression of shRNA was driven by a tetracycline-responsive Pol III hybrid
promoter. For experiments, purified endotoxin-free plasmid extracts were
transfected into 3T3-F44 cells using Amaxa’s Nucleofector
TM (Lonza; Basel,
Switzerland) with a Cell Line Nucleofector Kit V (Amaxa; Cologne, Germany). The
3T3-F442AcellswerethenharvestedandresuspendedinNucleofection
TMsolutionat
3.0310
6cells/100 ml.After theaddition of2.5 mgshRNAexpression vectors, thecells
were transfected using Nucleofector and seeded onto 35-mm plates at a near-
confluent density of 4310
5 in the absence or presence of 1 mg/ml doxycycline.
Transfected cells were induced to differentiate with St/Dex 2 days after transfection.
Differentiation experiments were carried out using the same media and culture
conditions as described earlier, and the knockdown efficiency was verified by relative
quantitative RT-PCR assays.
Relative-quantitative RT-PCR. Cellular RNA was isolated with TRIzolH from
cultured cells. Two micrograms of total RNA was transcribed into cDNA using
reverse transcriptase (Invitrogen) according to the manufacturer’s instructions.
Relative-quantitative PCR (qRT-PCR) was carried out using the FastStart Universal
Sybr Green Master (Rox) kit (Roche Applied Science; Mannheim, Germany), and
amplificationwasperformedona7500real-timethermalcycler(AppliedBiosystems;
Carlsbad, CA). Specific primers for each gene are listed in Supplementary Table S2.
Expression values were determined by the 2
2DDCTformula using the expression of the
ribosomal phosphoprotein large P0 (rplp0) gene as the normalizing factor.
Immunoblotting.Atthetimesindicated,cellswerelysedwithProteoJetMammalian
Cell Lysis Reagent (Fermentas Inc., Glen Burnie, MA) supplemented with
CompleteH protease inhibitor (Roche Applied Science) and phosphatase inhibitors.
Proteins were separated by SDS/PAGE and immunoblotted with antibodies against
human phospho-C/EBPb Thr235 (the equivalent of murine Thr188) from Cell
Signaling Technology (Berkeley, CA), phospho-GSK3b Ser9 (Abcam; Cambridge,
UK), C/EBPb and phospho-GSK3b Tyr216 from Santa Cruz Biotechnology (Santa
Cruz, CA), and with Rab Guanine Nucleotide Dissociation Inhibitor (GDI,
Invitrogen).
Data management and statistical analysis. Data are presented as the mean plus/
minusstandarddeviationofthemean.Datawereanalyzedbythetwo-tailedStudent’s
t-test for means analysis when comparing two data groups, or analysis of variance
(ANOVA) when comparing three or more data groups. Statistical significance was
identified if the P value was lower than 0.05.
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